ZA200810460B - Modified beta-lactamase and method for its preparation - Google Patents

Modified beta-lactamase and method for its preparation

Info

Publication number: ZA200810460B
Authority: ZA; South Africa
Prior art keywords: lactamase; preparation; modified beta; beta; modified
Prior art date: 2006-06-21

Application number

ZA200810460A

Other languages

English (en)

Inventor

Susanna Kaeaeriaeinen

Nina Wickstrand

Pertti Koski

Original Assignee

Ipsat Therapies Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-21

Filing date

2008-12-10

Publication date

2009-12-30

2008-12-10 Application filed by Ipsat Therapies Oy filed Critical Ipsat Therapies Oy

2009-12-30 Publication of ZA200810460B publication Critical patent/ZA200810460B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Toxicology (AREA)
Biophysics (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

ZA200810460A 2006-06-21 2008-12-10 Modified beta-lactamase and method for its preparation ZA200810460B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FI20065431A FI119190B (fi)	2006-06-21	2006-06-21	Modifioitu beta-laktamaasi ja menetelmä sen valmistamiseksi

Publications (1)

Publication Number	Publication Date
ZA200810460B true ZA200810460B (en)	2009-12-30

Family

ID=36651526

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200810460A ZA200810460B (en)	2006-06-21	2008-12-10	Modified beta-lactamase and method for its preparation

Country Status (15)

Country	Link
US (1)	US7989192B2 (xx)
EP (1)	EP2038411B1 (xx)
JP (1)	JP5306191B2 (xx)
KR (1)	KR101609243B1 (xx)
CN (1)	CN101484577A (xx)
AU (1)	AU2007262916B2 (xx)
BR (1)	BRPI0713726B1 (xx)
CA (1)	CA2659691C (xx)
ES (1)	ES2452321T3 (xx)
FI (1)	FI119190B (xx)
NO (1)	NO342006B1 (xx)
NZ (1)	NZ573696A (xx)
RU (1)	RU2009101795A (xx)
WO (1)	WO2007147945A1 (xx)
ZA (1)	ZA200810460B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI20105572A0 (fi)	2010-05-24	2010-05-24	Prevab R Lcc	Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt
AU2011268310A1 (en) *	2010-06-16	2013-01-10	Abbvie Inc.	Comparison of protein samples
TW201239355A (en)	2011-03-23	2012-10-01	Abbott Lab	Methods and systems for the analysis of protein samples
EP3156496B1 (fr) *	2011-04-21	2019-04-10	Biomérieux Inc.	Procede de detection d'au moins un mecanisme de resistance aux cephalosporines par spectrometrie de masse
CN106163546B (zh)	2014-04-17	2021-02-19	合成生物制品有限公司	具有改进的治疗性质的β-内酰胺酶
EP3186379B1 (en)	2014-08-28	2020-04-08	Synthetic Biologics, Inc.	E. coli-based production of beta-lactamase
EP3204495B1 (en)	2014-10-08	2020-04-22	Synthetic Biologics, Inc.	Beta-lactamase formulations and uses thereof
FR3027307B1 (fr)	2014-10-16	2016-11-04	Azurrx Sas	Molecule proteique hybride apte a inhiber au moins un antibiotique et composition pharmaceutique la comportant
EP3236993B1 (en)	2014-12-23	2023-09-13	Theriva Biologics, Inc.	Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
JP6810697B2 (ja)	2015-02-23	2021-01-13	シンセティック・バイオロジクス・インコーポレイテッド	腸内マイクロバイオームの保護のために抗生物質と共に使用するカルバペネマーゼ
WO2016144856A1 (en)	2015-03-06	2016-09-15	Synthetic Biologics, Inc.	Safe and effective beta-lactamase dosing for microbiome protection
US10988749B2 (en)	2016-02-23	2021-04-27	Da Volterra	Beta-lactamase variants
KR20180110032A (ko) *	2016-02-23	2018-10-08	다 볼떼라	베타-락타마제 변이체
KR20210040395A (ko)	2018-08-05	2021-04-13	다 볼떼라	이식편 대 숙주 질환의 치료를 위한 조성물
US20210299170A1 (en)	2018-08-05	2021-09-30	Da Volterra	Method for improving anticancer agent efficacy
US20220154156A1 (en) *	2019-03-11	2022-05-19	Regents Of The University Of Minnesota	Proteins and methods for disrupting bacterial communication
CN115104030B (zh) *	2019-12-30	2025-11-21	希真医疗财团	碳青霉烯类抗生素耐药病原菌株的直接检测方法
EP4148136A1 (en)	2021-09-08	2023-03-15	Da Volterra	An engineered yeast cell for the delivery of antibiotic-inactivating enzymes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI920206A0 (fi)	1992-01-17	1992-01-17	Pekka Untamo Heino	Medicinsk anvaendning, medicinskt foerfarande och preparat.
FI112666B (fi) *	2001-11-06	2003-12-31	Ipsat Therapies Oy	Itiöimätön Bacillus subtilis, sen valmistus ja käyttö
FR2843302B1 (fr) *	2002-08-09	2004-10-22	Centre Nat Rech Scient	Forme galenique pour la delivrance colique de principes actifs

2006
- 2006-06-21 FI FI20065431A patent/FI119190B/fi not_active IP Right Cessation
2007
- 2007-06-19 NZ NZ573696A patent/NZ573696A/en not_active IP Right Cessation
- 2007-06-19 BR BRPI0713726-5A patent/BRPI0713726B1/pt active IP Right Grant
- 2007-06-19 US US12/304,874 patent/US7989192B2/en active Active
- 2007-06-19 EP EP07765926.6A patent/EP2038411B1/en active Active
- 2007-06-19 WO PCT/FI2007/050372 patent/WO2007147945A1/en not_active Ceased
- 2007-06-19 CN CNA200780023477XA patent/CN101484577A/zh active Pending
- 2007-06-19 RU RU2009101795/10A patent/RU2009101795A/ru not_active Application Discontinuation
- 2007-06-19 ES ES07765926.6T patent/ES2452321T3/es active Active
- 2007-06-19 JP JP2009515904A patent/JP5306191B2/ja active Active
- 2007-06-19 AU AU2007262916A patent/AU2007262916B2/en not_active Ceased
- 2007-06-19 KR KR1020097001283A patent/KR101609243B1/ko not_active Expired - Fee Related
- 2007-06-19 CA CA2659691A patent/CA2659691C/en active Active
2008
- 2008-12-10 ZA ZA200810460A patent/ZA200810460B/xx unknown
2009
- 2009-01-19 NO NO20090297A patent/NO342006B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP2038411A1 (en)	2009-03-25
FI20065431A0 (fi)	2006-06-21
BRPI0713726A2 (pt)	2012-10-30
ES2452321T3 (es)	2014-03-31
FI119190B (fi)	2008-08-29
JP2009540814A (ja)	2009-11-26
KR101609243B1 (ko)	2016-04-05
WO2007147945A1 (en)	2007-12-27
NO342006B1 (no)	2018-03-12
NO20090297L (no)	2009-01-19
KR20090046787A (ko)	2009-05-11
US7989192B2 (en)	2011-08-02
WO2007147945A8 (en)	2009-07-30
NZ573696A (en)	2011-09-30
US20090181004A1 (en)	2009-07-16
CA2659691C (en)	2015-05-19
EP2038411A4 (en)	2010-04-07
RU2009101795A (ru)	2010-07-27
CA2659691A1 (en)	2007-12-27
AU2007262916B2 (en)	2013-12-05
AU2007262916A1 (en)	2007-12-27
FI20065431L (fi)	2007-12-22
CN101484577A (zh)	2009-07-15
EP2038411B1 (en)	2014-02-26
BRPI0713726B1 (pt)	2023-01-10
JP5306191B2 (ja)	2013-10-02

Publication	Publication Date	Title
ZA200810460B (en)	2009-12-30	Modified beta-lactamase and method for its preparation
TWI340555B (en)	2011-04-11	Ad convertere and adconversion method
ZA200805990B (en)	2009-04-29	New method and system
IL192419A0 (en)	2011-08-01	Anti-ephb4 antibodies and methods using same
GB201109817D0 (en)	2011-07-27	System and method
EP2069901A4 (en)	2010-10-06	METHOD AND SYSTEM FOR SELECTION
KR101500766B9 (ko)	2024-09-25	치환된 3-이소부틸-9,10-디메톡시-1,3,4,6,7,11ｂ-헥사히드로-2Ｈ-피리도[2,1-ａ]이소퀴놀린-2-올 화합물 및 그와 관련된 방법
GB0601961D0 (en)	2006-03-15	Method
EP2121756A4 (en)	2011-08-31	ANTIBODIES AND PROCESS FOR THEIR PREPARATION AND USE
PL1900949T3 (pl)	2019-07-31	Element poślizgowy i sposób jego wytwarzania
IL247957A0 (en)	2016-11-30	Anti-ephrinb2 antibodies and methods of using them
EP1972615A4 (en)	2011-04-13	CYCLOALCANECARBOXAMIDE DERIVATIVE AND METHOD FOR PRODUCING THE SAME
PL2132251T3 (pl)	2017-05-31	Kompozycja i sposób
GB201008346D0 (en)	2010-07-07	Methods and compounds for phototransfer
GB0601699D0 (en)	2006-03-08	Method
GB0602449D0 (en)	2006-03-22	Chuck and method
PT2122108T (pt)	2016-12-09	Configuração e método de perfuração
GB0608966D0 (en)	2006-06-14	Method and product
GB0620930D0 (en)	2006-11-29	Composition and method for use thereof
GB0625208D0 (en)	2007-01-24	Composition and method
EP2062060A4 (en)	2017-07-26	Measuring head and measuring method
GB0600261D0 (en)	2006-02-15	Composition and method
ZA200806053B (en)	2009-12-30	Anti-EphB4 antibodies and methods using same
GB0621272D0 (en)	2006-12-06	Assay and method
GB0604315D0 (en)	2006-04-12	Composition and method